Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Olivia Brayer is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/20/2025 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 26.26% | Olivia Brayer62% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -4.86% | Olivia Brayer62% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert |
| 02/04/2025 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | -7.76% | Olivia Brayer62% | $50 → $55 | Maintains | Neutral | Get Alert |
| 01/31/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -4.86% | Olivia Brayer62% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -4.86% | Olivia Brayer62% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert |
| 12/12/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 26.26% | Olivia Brayer62% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 12/11/2024 | GILD | Buy Now | Gilead Sciences | $107.38 | -25.5% | Olivia Brayer62% | $80 → $80 | Reiterates | Neutral → Neutral | Get Alert |
| 11/14/2024 | OMER | Buy Now | Omeros | $9.05 | — | Olivia Brayer62% | — | Reiterates | → Neutral | Get Alert |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $107.38 | -25.5% | Olivia Brayer62% | $70 → $80 | Maintains | Neutral | Get Alert |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -4.86% | Olivia Brayer62% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 26.26% | Olivia Brayer62% | $110 → $90 | Maintains | Overweight | Get Alert |
| 10/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 60.18% | Olivia Brayer62% | $1015 → $1015 | Reiterates | Neutral → Neutral | Get Alert |
| 10/22/2024 | AMGN | Buy Now | Amgen | $304.05 | 33.2% | Olivia Brayer62% | $405 → $405 | Reiterates | Overweight → Overweight | Get Alert |
| 10/18/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | -16.15% | Olivia Brayer62% | $50 → $50 | Reiterates | Neutral → Neutral | Get Alert |
| 10/11/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -21.94% | Olivia Brayer62% | $220 → $220 | Reiterates | Neutral → Neutral | Get Alert |
| 10/08/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -4.86% | Olivia Brayer62% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert |
| 09/27/2024 | AMGN | Buy Now | Amgen | $304.05 | 33.2% | Olivia Brayer62% | → $405 | Initiates | → Overweight | Get Alert |
| 09/16/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 60.18% | Olivia Brayer62% | $1015 → $1015 | Reiterates | Neutral → Neutral | Get Alert |
| 09/16/2024 | GILD | Buy Now | Gilead Sciences | $107.38 | -34.81% | Olivia Brayer62% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 09/16/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | -16.15% | Olivia Brayer62% | $50 → $50 | Reiterates | Neutral → Neutral | Get Alert |
| 09/16/2024 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.61 | 16.14% | Olivia Brayer62% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 60.18% | Olivia Brayer62% | $1015 → $1015 | Reiterates | Neutral → Neutral | Get Alert |
| 09/09/2024 | GILD | Buy Now | Gilead Sciences | $107.38 | -34.81% | Olivia Brayer62% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 09/09/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 54.32% | Olivia Brayer62% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.61 | 16.14% | Olivia Brayer62% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -21.94% | Olivia Brayer62% | $220 → $220 | Reiterates | Neutral → Neutral | Get Alert |
| 08/09/2024 | GILD | Buy Now | Gilead Sciences | $107.38 | -34.81% | Olivia Brayer62% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert |
| 08/05/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 54.32% | Olivia Brayer62% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 08/02/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -4.86% | Olivia Brayer62% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -4.86% | Olivia Brayer62% | $440 → $480 | Maintains | Overweight | Get Alert |
| 07/22/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 57.81% | Olivia Brayer62% | $925 → $1000 | Maintains | Neutral | Get Alert |
| 07/22/2024 | GILD | Buy Now | Gilead Sciences | $107.38 | -34.81% | Olivia Brayer62% | $75 → $70 | Maintains | Neutral | Get Alert |
| 07/22/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | -24.53% | Olivia Brayer62% | $45 → $45 | Reiterates | Neutral → Neutral | Get Alert |
| 07/22/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 54.32% | Olivia Brayer62% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -21.94% | Olivia Brayer62% | $150 → $220 | Maintains | Neutral | Get Alert |
| 07/01/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -46.78% | Olivia Brayer62% | $150 → $150 | Reiterates | Neutral → Neutral | Get Alert |
| 05/09/2024 | MNKD | Buy Now | MannKind | $5.19 | 25.24% | Olivia Brayer62% | $6.5 → $6.5 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 45.98% | Olivia Brayer62% | $925 → $925 | Reiterates | Neutral → Neutral | Get Alert |
| 04/25/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 54.32% | Olivia Brayer62% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 04/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 45.98% | Olivia Brayer62% | → $925 | Reiterates | Neutral → Neutral | Get Alert |
| 03/15/2024 | MNKD | Buy Now | MannKind | $5.19 | 25.24% | Olivia Brayer62% | $6.5 → $6.5 | Reiterates | Overweight → Overweight | Get Alert |
| 02/28/2024 | MNKD | Buy Now | MannKind | $5.19 | 25.24% | Olivia Brayer62% | $6.5 → $6.5 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 40.29% | Olivia Brayer62% | $100 → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.61 | 16.14% | Olivia Brayer62% | $12 → $10 | Maintains | Overweight | Get Alert |
| 02/23/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -46.78% | Olivia Brayer62% | $165 → $150 | Maintains | Neutral | Get Alert |
| 02/20/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -12.79% | Olivia Brayer62% | $440 → $440 | Reiterates | Overweight → Overweight | Get Alert |
| 02/20/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -41.46% | Olivia Brayer62% | → $165 | Reiterates | Neutral → Neutral | Get Alert |
| 02/15/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -41.46% | Olivia Brayer62% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert |
| 02/12/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -41.46% | Olivia Brayer62% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert |
| 02/07/2024 | GILD | Buy Now | Gilead Sciences | $107.38 | -27.36% | Olivia Brayer62% | $80 → $78 | Maintains | Neutral | Get Alert |
| 02/06/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -12.79% | Olivia Brayer62% | $440 → $440 | Reiterates | Overweight → Overweight | Get Alert |
| 02/06/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 45.98% | Olivia Brayer62% | $850 → $925 | Maintains | Neutral | Get Alert |
| 01/24/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -12.79% | Olivia Brayer62% | $415 → $440 | Maintains | Overweight | Get Alert |
| 01/22/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -41.46% | Olivia Brayer62% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert |
| 01/18/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -41.46% | Olivia Brayer62% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert |
| 01/12/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -17.75% | Olivia Brayer62% | $415 → $415 | Reiterates | Overweight → Overweight | Get Alert |
| 01/09/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -17.75% | Olivia Brayer62% | $415 → $415 | Reiterates | Overweight → Overweight | Get Alert |
| 01/09/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.66 | 34.14% | Olivia Brayer62% | $850 → $850 | Reiterates | Neutral → Neutral | Get Alert |
| 12/14/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -24.68% | Olivia Brayer62% | $380 → $380 | Reiterates | Overweight → Overweight | Get Alert |
| 12/14/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -41.46% | Olivia Brayer62% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert |
| 12/05/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -24.68% | Olivia Brayer62% | $380 → $380 | Reiterates | Overweight → Overweight | Get Alert |
| 11/16/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -24.68% | Olivia Brayer62% | → $380 | Reiterates | Overweight → Overweight | Get Alert |
| 11/15/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | -7.76% | Olivia Brayer62% | $68 → $55 | Downgrade | Overweight → Neutral | Get Alert |
| 11/07/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -24.68% | Olivia Brayer62% | $370 → $380 | Maintains | Overweight | Get Alert |
| 11/02/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 40.29% | Olivia Brayer62% | $120 → $100 | Maintains | Overweight | Get Alert |
| 10/16/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 68.35% | Olivia Brayer62% | → $120 | Reiterates | Overweight → Overweight | Get Alert |
| 10/16/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -26.67% | Olivia Brayer62% | → $370 | Reiterates | Overweight → Overweight | Get Alert |
| 10/16/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -39.68% | Olivia Brayer62% | $190 → $170 | Maintains | Neutral | Get Alert |
| 10/09/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | 25.78% | Olivia Brayer62% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 09/15/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | 25.78% | Olivia Brayer62% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 09/14/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 68.35% | Olivia Brayer62% | → $120 | Reiterates | Overweight → Overweight | Get Alert |
| 09/14/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -32.59% | Olivia Brayer62% | → $190 | Reiterates | Neutral → Neutral | Get Alert |
| 09/13/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 68.35% | Olivia Brayer62% | → $120 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -26.67% | Olivia Brayer62% | → $370 | Reiterates | Overweight → Overweight | Get Alert |
| 08/16/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -32.59% | Olivia Brayer62% | → $190 | Reiterates | Neutral → Neutral | Get Alert |
| 08/08/2023 | MNKD | Buy Now | MannKind | $5.19 | 44.51% | Olivia Brayer62% | $6.5 → $7.5 | Maintains | Overweight | Get Alert |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -26.67% | Olivia Brayer62% | $365 → $370 | Reiterates | Overweight → Overweight | Get Alert |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 68.35% | Olivia Brayer62% | → $120 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $107.38 | -25.5% | Olivia Brayer62% | → $80 | Reiterates | Neutral → Neutral | Get Alert |
| 07/20/2023 | GILD | Buy Now | Gilead Sciences | $107.38 | -25.5% | Olivia Brayer62% | $85 → $80 | Maintains | Neutral | Get Alert |
| 07/20/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | 42.55% | Olivia Brayer62% | $88 → $85 | Maintains | Overweight | Get Alert |
| 07/13/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -29.04% | Olivia Brayer62% | → $200 | Reiterates | Neutral → Neutral | Get Alert |
| 07/12/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -29.04% | Olivia Brayer62% | → $200 | Reiterates | Neutral → Neutral | Get Alert |
| 07/06/2023 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.61 | 74.22% | Olivia Brayer62% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 06/23/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -27.66% | Olivia Brayer62% | $365 → $365 | Reiterates | Overweight → Overweight | Get Alert |
| 06/23/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -29.04% | Olivia Brayer62% | $200 → $200 | Reiterates | Neutral → Neutral | Get Alert |
| 06/22/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -29.04% | Olivia Brayer62% | → $200 | Reiterates | Neutral → Neutral | Get Alert |
| 05/30/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -27.66% | Olivia Brayer62% | → $365 | Reiterates | Overweight → Overweight | Get Alert |
| 04/13/2023 | CRSP | Buy Now | CRISPR Therapeutics | $40.95 | 75.82% | Olivia Brayer62% | → $72 | Initiates | → Overweight | Get Alert |
| 02/23/2023 | GRPH | Buy Now | Graphite Bio | — | — | Olivia Brayer62% | $56 → $21 | Downgrade | Overweight → Neutral | Get Alert |
| 01/17/2023 | BMY | Buy Now | Bristol-Myers Squibb | $59.63 | 59.32% | Olivia Brayer62% | → $95 | Initiates | → Overweight | Get Alert |
| 09/15/2022 | GRPH | Buy Now | Graphite Bio | — | — | Olivia Brayer62% | → $84 | Initiates | → Overweight | Get Alert |
| 07/13/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 54.32% | Olivia Brayer62% | → $110 | Initiates | → Overweight | Get Alert |
| 07/13/2022 | GILD | Buy Now | Gilead Sciences | $107.38 | -34.81% | Olivia Brayer62% | → $70 | Initiates | → Neutral | Get Alert |
| 07/13/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $504.54 | -27.66% | Olivia Brayer62% | → $365 | Initiates | → Overweight | Get Alert |
| 07/13/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -37.91% | Olivia Brayer62% | → $175 | Initiates | → Neutral | Get Alert |
| 05/05/2022 | AUPH | Buy Now | Aurinia Pharmaceuticals | $8.61 | 190.36% | Olivia Brayer62% | → $25 | Assumes | → Overweight | Get Alert |
| 12/18/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -37.55% | Olivia Brayer62% | $159 → $176 | Reiterates | → Overweight | Get Alert |
| 11/21/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -43.59% | Olivia Brayer62% | $150 → $159 | Maintains | Overweight | Get Alert |
| 04/15/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -51.04% | Olivia Brayer62% | $135 → $138 | Maintains | Overweight | Get Alert |
| 10/01/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $281.84 | -52.1% | Olivia Brayer62% | → $135 | Initiates | → Overweight | Get Alert |
| 10/01/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.28 | 76.77% | Olivia Brayer62% | → $126 | Initiates | → Overweight | Get Alert |
